Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

113 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cell-free DNA screening for trisomy 21 in twin pregnancy: a large multicenter cohort study.
Dugoff L, Koelper NC, Chasen ST, Russo ML, Roman AS, Limaye MA, Ranzini AC, Clifford CM, Biggio JR Jr, Subramaniam A, Seasely A, Patil AS, Weed S, Page JM, Nicholas S, Idler J, Rao RR, Crowder A, Shree R, McLennan G, Bromley B. Dugoff L, et al. Am J Obstet Gynecol. 2023 Oct;229(4):435.e1-435.e7. doi: 10.1016/j.ajog.2023.04.002. Epub 2023 Apr 6. Am J Obstet Gynecol. 2023. PMID: 37030426
First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial).
Dugoff L, Hobbins JC, Malone FD, Porter TF, Luthy D, Comstock CH, Hankins G, Berkowitz RL, Merkatz I, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Vidaver J, D'Alton ME. Dugoff L, et al. Am J Obstet Gynecol. 2004 Oct;191(4):1446-51. doi: 10.1016/j.ajog.2004.06.052. Am J Obstet Gynecol. 2004. PMID: 15507981
Quad screen as a predictor of adverse pregnancy outcome.
Dugoff L, Hobbins JC, Malone FD, Vidaver J, Sullivan L, Canick JA, Lambert-Messerlian GM, Porter TF, Luthy DA, Comstock CH, Saade G, Eddleman K, Merkatz IR, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, D'Alton ME; FASTER Trial Research Consortium. Dugoff L, et al. Obstet Gynecol. 2005 Aug;106(2):260-7. doi: 10.1097/01.AOG.0000172419.37410.eb. Obstet Gynecol. 2005. PMID: 16055573
Is there a nuchal translucency millimeter measurement above which there is no added benefit from first trimester serum screening?
Comstock CH, Malone FD, Ball RH, Nyberg DA, Saade GR, Berkowitz RL, Ferreira J, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Bianchi DW, D'Alton ME; FASTER Research Consortium. Comstock CH, et al. Among authors: dugoff l. Am J Obstet Gynecol. 2006 Sep;195(3):843-7. doi: 10.1016/j.ajog.2006.06.006. Am J Obstet Gynecol. 2006. PMID: 16949423
Comparison of serum markers in first-trimester down syndrome screening.
Canick JA, Lambert-Messerlian GM, Palomaki GE, Neveux LM, Malone FD, Ball RH, Nyberg DA, Comstock CH, Bukowski R, Saade GR, Berkowitz RL, Dar P, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, D'Alton ME; First and Second Trimester Evaluation of Risk (FASTER) Trial Research Consortium. Canick JA, et al. Among authors: dugoff l. Obstet Gynecol. 2006 Nov;108(5):1192-9. doi: 10.1097/01.AOG.0000241095.19638.f2. Obstet Gynecol. 2006. PMID: 17077242
113 results